The Comprehensive Cancer Center has been selected as one of six beneficiaries of a shoe sale on QVC that raises money for breast cancer research and education programs.

More than 100,000 pairs of designer shoes from members of the Fashion Footwear Association of New York (FFANY) will be offered at half the retail price, with a portion of the net proceeds benefiting the Cancer Center. The ninth annual “FFANY Shoes on Sale” will air from 7–10 p.m. Oct. 16.

“The University of Michigan Cancer Center is honored and excited to again be a part of the Shoes On Sale benefit,” says Dr. Daniel Hayes, clinical director of the Breast Oncology Program. “This national event directly impacts our local community by providing funding for our research center, and it helps increase breast cancer education and awareness for women everywhere.”

FFANY and QVC chose the Cancer Center as a beneficiary “because of its ground-breaking breast cancer research, state-of-the-art facility and the level of care provided for its patients,” says Joseph Moore, president of FFANY.

Since the event began eight years ago, Shoes on Sale has raised more than $10 million for breast cancer research and education programs at prominent cancer centers nationwide, QVC President and CEO Doug Briggs says.

The other facilities selected for the 2002 event are: The Gillette Center for Women’s Cancers at Dana-Farber Cancer Institute, The Joyce Eisenberg Keefer Breast Center at the John Wayne Cancer Institute, Long Island Cancer Center at Stony Brook University and The Abramson Cancer Center of the University of Pennsylvania. Additionally, the National Women’s Cancer Research Alliance will distribute funds among its member hospitals, which include Columbia University; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; the University of Washington Medical Center; the University of California, Los Angeles; the University of Alabama; the University of Chicago; and the University of Texas.
With more than 750,000 pairs of shoes sold since the first benefit event in Oct. 1994, the 2002 gala is expected to bring the cumulative net proceeds to more than $12 million.